PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.40%
Revenue growth of 2.40% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
3.40%
Gross profit growth of 3.40% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
-2.91%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
4.04%
Operating income growth of 4.04% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
-15.54%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-15.54%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-15.54%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.00%
Share reduction exceeding 1.5x Healthcare median of 0.07%. Joel Greenblatt would applaud significant buybacks if they are value-accretive.
0.00%
Diluted share change of 0.00% while Healthcare median is zero. Walter Schloss might see a slight difference in equity issuance policy.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.57%
10Y CAGR of 59.57% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
57.04%
5Y CAGR of 57.04% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
29.96%
3Y CAGR of 29.96% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.45%
Net income/share CAGR exceeding 1.5x Healthcare median of 11.07% over a decade. Joel Greenblatt might see a standout compounder of earnings.
86.04%
5Y net income/share CAGR > 1.5x Healthcare median of 13.32%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
9.43%
3Y net income/share CAGR 1.25-1.5x Healthcare median. Mohnish Pabrai would confirm expansions or margin boosts drive the short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
130.07%
5Y equity/share CAGR > 1.5x Healthcare median of 7.03%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
62.57%
3Y equity/share CAGR > 1.5x Healthcare median of 2.61%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
-100.00%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.20%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-3.35%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
0.06%
Asset growth of 0.06% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.14%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-41.08%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
96.39%
SG&A growth of 96.39% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.